NORTREL 7/7/7 Drug Patent Profile
Which patents cover Nortrel 7/7/7, and when can generic versions of Nortrel 7/7/7 launch?
Nortrel 7/7/7 is a drug marketed by Barr and is included in one NDA.
The generic ingredient in NORTREL 7/7/7 is ethinyl estradiol; norethindrone. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORTREL 7/7/7?
- What are the global sales for NORTREL 7/7/7?
- What is Average Wholesale Price for NORTREL 7/7/7?
Summary for NORTREL 7/7/7
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Patent Applications: | 223 |
| DailyMed Link: | NORTREL 7/7/7 at DailyMed |
US Patents and Regulatory Information for NORTREL 7/7/7
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | NORTREL 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 075478-001 | Aug 30, 2002 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Barr | NORTREL 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 075478-002 | Aug 30, 2002 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
